Filing Details
- Accession Number:
- 0000950170-25-044469
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-25 16:39:57
- Reporting Period:
- 2025-03-21
- Filing Date:
- 2025-03-25
- Accepted Time:
- 2025-03-25 16:39:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1713863 | Rafael Holdings Inc. | RFL | Pharmaceutical Preparations (2834) | 822296593 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1852018 | William Conkling | C/O Rafael Holdings, Inc. 520 Broad St Newark NJ 07102 | Chief Executive Officer | No | No | No | No |
Transaction Summary
Number of Shares After Transactions: | 537,001 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class B Common Stock, Par Value $.01 Per Share | Disposition | 2025-03-21 | 14,814 | $1.93 | 537,001 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct |
Footnotes
- Represents shares withheld by the Issuer for tax purposes upon the vesting of Restricted Stock.
- Consists of 146,955 shares of stock held directly, 183,094 fully vested shares of Restricted Stock and 206,952 shares of unvested Restricted Stock that vest as follows: 38,983 shares to vest quarterly, June 21, 2025 through September 21, 2025, and 38,986 shares to vest on December 21, 2025; 10,000 shares to vest on each of October 25, 2025, October 25, 2026 and October 25, 2027; and 15,000 shares to vest on each of January 13, 2026, January 13, 2027, January 13, 2028 and January 13, 2029.